Muna Therapeutics has raised $73 million to develop small-molecule treatments for Alzheimer’s and other neurodegenerative diseases. The series A will bankroll work on drugs to repair neuronal dysfunction, resolve neuroinflammation and restore neuroprotection and resilience to disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,